With a new high-tech 3D stem cell technology BTech, a former spin-off of the Luxembourg Centre for Systems Biomedicine (LCSB), supports pharmaceutical companies in the drug discovery and preclinical testing phase to increase their efficiency and the success rate of compounds that pass the clinical trials, i.e. enhanced relevance.
We focus on central nervous system (CNS) diseases, CRO services in regards to higly sophisticated tissue engineering and Insilico computerial screening technologies .
BTech ‘s technology allows pre-clinical testings of novel compounds in a human disease relevant model for their potential application for treatment of various diseases .
New high-tech 3D technology mimicking human disease and complexity in various Organs. Cost-effective service due to less required media usage with 96-well format.
Reduces animal testing as innovative alternative in vitro technology platform
We guarantee high standards of data storage and security
While the focus of our service is on the above described pre-clinical drug testing, we also offer the possibility to conduct toxicology studies.
Additionally, we also see the potential of addressing other neurodegenerative disorders, several personalized medicine related applications and insilico screening.